Safety and Efficacy of AAV9/AP4B1 (BFB-101) For Patients With AP4B1-related Hereditary Spastic Paraplegia Type 47 (SPG47)

Clinical trial NCT06948019 · NOT_YET_RECRUITING

Trial details

NCT number: NCT06948019
Sponsor: BlackfinBio Ltd
Status: NOT_YET_RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

HSP Hereditary Spastic Paraplegia Hereditary Spastic Paraparesis Hereditary Spastic Paraplegia Type 50 Hereditary Spastic Paraplegia Type 47 Hereditary Spastic Paraplegia Type 51 Hereditary Spastic Paraplegia Type 52 SPG47 AP4B1 Neurogenetic Disorders Neurodevelopmental Conditions Movement Disorders

Start date: 2025-08-01
Primary completion: 2030-08-01
Enrollment: 5

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.